-
Teva Pharmaceutical Industries Limited 2018 Q4 - Results - Earnings Call Slides
Post on 2/14/19
-
PTC Therapeutics Launches Fifth Annual STRIVE Grant Award Program for Duchenne Muscular Dystrophy
Post on 2/13/19
-
Inovio Pharmaceuticals Announces Proposed Convertible Senior Notes Offering
Post on 2/13/19
-
Johnson & Johnson To Acquire Auris Health For $3.4B
Post on 2/13/19
-
Better Buy: Gilead Sciences vs. Pfizer
Post on 2/13/19
-
Palatin Technologies Provides Corporate Update
Post on 2/12/19
-
ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors
Post on 2/12/19
-
Avantor Begins Process For U.S. IPO
Post on 2/12/19
-
Topcon Healthcare Solutions and Oculo Form Global Partnership
Post on 2/11/19
-
Is Celgene a Buy?
Post on 2/11/19
-
Celldex Therapeutics Announces Reverse Stock Split
Post on 2/8/19
-
Medical Transcription Billing, Corp. Officially Changes Company Name to MTBC
Post on 2/7/19
-
BioAegis Therapeutics Expands Phase 1b/2a Community-Acquired Pneumonia Study to the Republic of Georgia
Post on 2/7/19
-
Tabula Rasa HealthCare Announces Proposed $250 Million Offering
Post on 2/7/19
-
Science Center Just Gave $700K to Support Four Local Researchers
Post on 2/6/19
-
Celgene/Bristol-Myers: Analyzing The News Of Starboard's Stake
Post on 2/6/19
-
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 2/5/19
-
Better Buy: Johnson & Johnson vs. Merck & Co.
Post on 2/5/19
-
Celgene Highlights What Bristol-Myers Squibb Is Getting
Post on 2/5/19
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 2/4/19
-
RxAnte Announces Partnership with Geisinger Health Plan
Post on 2/4/19
-
AmeriHealth Caritas Awarded Contract to Serve North Carolina’s Medicaid Population
Post on 2/4/19
-
AmeriHealth Caritas Awarded Contract to Serve North Carolina’s Medicaid Population
Post on 2/4/19
-
The Results Are In, and It's Clear Celgene Doesn't Need Bristol-Myers Squibb
Post on 2/4/19
-
Better Buy: Johnson & Johnson vs. AbbVie
Post on 2/4/19